Hints and tips:
...“As part of the ongoing review process, [the EMA] has additional questions, which we are answering expeditiously,” Novavax told the Financial Times....
...Sanofi will take a roughly 5 per cent stake in Novavax....
...Novavax was “committed” to continuing to deliver its vaccine, she added....
...Novavax refused to comment on whether it would concede to Shah’s push for board seats....
...Less successful vaccine makers have fallen back even more significantly: shares in Novavax, whose Covid shot has sold far fewer than the messenger RNA jabs, have fallen 97 per cent since early 2021....
...“Countries can renegotiate but they will probably need to pay a portion of their contracts to compensate Novavax,” said Song....
...But manufacturing and regulatory delays meant Novavax received the green light long after many countries had attempted a return to normality....
...CureVac and Novavax, two Covid-19 vaccine makers that appeared to be potential key players in allaying global supply constraints early in the pandemic, have appointed new chief executives....
...He said delays in vaccine shipments to Europe had also dented Novavax’s second-quarter results, which missed analysts’ expectations....
...Clinical trials show Novavax vaccine has 90 per cent efficacy against symptomatic Covid, similar to mRNA vaccines....
...Shares in Novavax, which cut its 2022 revenue forecast in half to between $2bn-$2.3bn in August, are down 86.2 per cent this year....
...In later-stage phase 3 trial results published in September, the Novavax flu vaccine had comparable results to the Sanofi flu shot....
...Novavax’s regulatory filings so far have been for the primary two doses....
...Greg Glenn, Novavax’s president of R&D, said the mRNA vaccines have some “safety” and issues in terms of adverse side effects, which would make Novavax a particularly attractive option when Covid-19 becomes...
...Novavax’s shot is protein based. It is given as two doses 21 days apart, and is stored at conventional fridge temperature....
...Novavax is targeting production of 2bn doses in 2022, he said....
...Novavax is now testing its efficacy against the new Omicron variant....
...Crucially, the submission, Novavax said, included data on chemistry and manufacturing control....
...Novavax said its Covid jab would be sold in Indonesia under the brand name Covovax....
...Novavax said that cross-reactive antibodies against the Delta variant increased six times compared to the primary vaccine series....
...Novavax received $1.6bn from Operation Warp Speed, helping fund production of 100m doses....
...Its first big hope, a jab for respiratory syncytial virus (RSV), barely failed in a phase 3 trial and Novavax couldn’t afford another one....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Meanwhile, plucky upstarts CureVac, Novavax and Valneva, which had once seemed set to make a meaningful contribution, are yet to deliver a vaccine. The laggards plead for more time....
International Edition